Australia markets closed

Evaxion Biotech A/S (EVAX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.1800+0.0600 (+1.46%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-22,125
-22,125
-23,169
-24,532
-15,018
Depreciation & amortisation
615
615
571
344
105
Deferred income taxes
-984
-984
-998
-190
-2,067
Stock-based compensation
479
479
942
1,379
3,408
Change in working capital
1,562
1,562
-2,877
1,237
215
Accounts payable
502
502
-599
-647
1,798
Other working capital
-17,778
-17,778
-26,066
-23,293
-12,831
Other non-cash items
1,358
1,358
-530
-992
137
Net cash provided by operating activities
-17,691
-17,691
-25,774
-21,933
-12,438
Cash flows from investing activities
Investments in property, plant and equipment
-87
-87
-292
-1,360
-393
Purchases of investments
-6
-6
-
-
-
Sales/maturities of investments
-
-
24
30
-
Net cash used for investing activities
-93
-93
-268
-1,330
-393
Cash flows from financing activities
Debt repayment
-697
-697
-424
-289
-74
Common stock issued
9,168
9,168
428
53,854
9,019
Other financing activities
-432
-432
-
-3,760
-128
Net cash used provided by (used for) financing activities
10,691
10,691
7,853
49,805
8,817
Net change in cash
-7,093
-7,093
-18,189
26,542
-4,014
Cash at beginning of period
13,184
13,184
32,166
5,834
9,559
Cash at end of period
5,583
5,583
13,184
32,166
5,834
Free cash flow
Operating cash flow
-17,691
-17,691
-25,774
-21,933
-12,438
Capital expenditure
-87
-87
-292
-1,360
-393
Free cash flow
-17,778
-17,778
-26,066
-23,293
-12,831